Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Alcon Research |
---|---|
Information provided by: | Alcon Research |
ClinicalTrials.gov Identifier: | NCT00051168 |
Long term safety study of TRAVATAN in patients with Open-angle glaucoma or ocular hypertension.
Condition | Intervention | Phase |
---|---|---|
Glaucoma, Open-Angle Ocular Hypertension |
Drug: Travoprost (0.004%) |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Long-Term Safety Study of Once-Daily TRAVATAN |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Adult patients of any race and either sex with chronic angle-closure glaucoma.
Study ID Numbers: | C-02-20 |
Study First Received: | January 3, 2003 |
Last Updated: | August 4, 2008 |
ClinicalTrials.gov Identifier: | NCT00051168 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Glaucoma POAG OAG OHT |
Glaucoma Eye Diseases Glaucoma, Open-Angle Vascular Diseases |
Travoprost Hypertension Ocular Hypertension |
Glaucoma Eye Diseases Glaucoma, Open-Angle Vascular Diseases |
Cardiovascular Diseases Ocular Hypertension Hypertension |